Loading...
*  Topical Drug Delivery Market by Product Type, Route of Administration & Region - 2021 | MarketsandMarkets
Ophthalmic, Vaginal, Nasal), Product Type (Formulation (Solid, Cream, Lotion, Paste, Liquid), Transdermal (Patch, Gel)), ... 148 Pages Report] Topical Drug Delivery Market Report categories the global market by Route of Administration (Rectal, Skin, ... On the basis of route of administration, the market is segmented into skin, ophthalmic, rectal, vaginal, and nasal routes. ... Route of Administration (Skin, Ophthalmic, Rectal, Vaginal, Nasal), & Facility of Use (Hospital, Clinic, Home care, Research ...
  https://www.marketsandmarkets.com/Market-Reports/topical-drug-delivery-market-124871717.html
*  FOR ORAL OR RECTAL ADMINISTRATION FOR THE PREVENTION AND TREATMENT OF PORTAL-SYSTEMIC ENCEPHALOPATHY - PDF
USP 10 g/15 ml FOR ORAL OR RECTAL ADMINISTRATION FOR THE PREVENTION AND TREATMENT OF PORTAL-SYSTEMIC ENCEPHALOPATHY Rx Only ... LUMIGAN (bimatoprost ophthalmic solution) 0.01% for topical ophthalmic use. Initial U.S. Approval: 2001 HIGHLIGHTS OF ... Administration of lactulose solution in the diet of mice for 18 months in concentrations of 3 and 10 percent (v/w) did not ... DOSAGE AND ADMINISTRATION Oral Adult: The usual adult, oral dosage is 2 to 3 tablespoonfuls (30 to 45 ml, containing 20 g to 30 ...
  http://docplayer.net/21801758-For-oral-or-rectal-administration-for-the-prevention-and-treatment-of-portal-systemic-encephalopathy.html
*  Patent US4649047 - Ophthalmic treatment by topical administration of cyclosporin - Google Patents
By requiring systemic administration in cyclosporin treatment of opthalmic diseases not limited to the eye surface, a patient ... The cyclosporin may be topically administered as an ophthalmic drop or ophthalmic ointment containing an effective amount of ... Ophthalmic compositionn and method of using same. US4937078 *. Aug 26, 1988. Jun 26, 1990. Mezei Associates Limited. Liposomal ... Veterinary treatment of ophthalmic disease in animals using toptical tacrolimus. US20040121944 *. Dec 20, 2002. Jun 24, 2004. ...
  http://www.google.com/patents/US4649047?dq=6,332,126
*  Single Administration Sustained Release Formats for Administration of Ophthalmic Medications to the Ocular Surface, Cornea and...
Single Administration Sustained Release Formats for Administration of Ophthalmic Medications to the Ocular Surface, Cornea and ... Single Administration Sustained Release Formats for Administration of Ophthalmic Medications to the Ocular Surface, Cornea and ... Shikha P Barman, Koushik Barman, Kevin Ward; Single Administration Sustained Release Formats for Administration of Ophthalmic ...
  https://iovs.arvojournals.org/article.aspx?articleid=2270086
*  Long Term Administration Study of OPC-12759 Ophthalmic Suspension - Full Text View - ClinicalTrials.gov
Long Term Administration Study of OPC-12759 Ophthalmic Suspension. The safety and scientific validity of this study is the ... Long Term Administration Study of OPC-12759 Ophthalmic Suspension in Dry Eye Patients. ... Experimental: OPC-12759 Ophthalmic suspension Instillation, 4times/day. Drug: OPC-12759 Ophthalmic suspension Instillation, ... The purpose of this study is to evaluate safety and efficacy of OPC-12759 ophthalmic suspension during 52 weeks in dry eye ...
  https://clinicaltrials.gov/show/NCT00818324
*  Comparison of Drug Concentrations in Human Aqueous Humor after the Administration of 0.3% Gatifloxacin Ophthalmic Gel, 0.3%...
Comparison of Drug Concentrations in Human Aqueous Humor after the Administration of 0.3% Gatifloxacin Ophthalmic Gel, 0.3% ... Purpose: To investigate the penetration of 0.3% gatifloxacin ophthalmic gel, 0.3% gatifloxacin ophthalmic solution and 0.5% ... Keywords: aqueous humor, levofloxacin, gatifloxacin, ophthalmic gel, ophthalmic solution This is an open access article ... Gatifloxacin Ophthalmic Gel, 0.3% Gatifloxacin and 0.5% Levofloxacin Ophthalmic Solutions. Int J Med Sci 2015; 12(6):517-523. ...
  http://www.medsci.org/v12p0517
*  Polymyxin B Sulfate eent Monograph for Professionals - Drugs.com
Ophthalmic Administration. In fixed combination with other anti-infectives and corticosteroids, apply topically to the eye as ... Polymyxin B Sulfate Dosage and Administration. Administration. Apply topically to the eye or ear.a b c d e f g h i j k l ... Ophthalmic Ointments. Ophthalmic ointments may delay corneal healing.f k l. Sensitivity Reactions. Hypersensitivity Reactions. ... Bacterial Ophthalmic Infections. Polymyxin B and Neomycin Sulfates and Bacitracin Zinc. Ophthalmic Ointment Apply to the ...
  https://www.drugs.com/monograph/polymyxin-b-sulfate-eent.html
*  Apraclonidine Hydrochloride Monograph for Professionals - Drugs.com
Ophthalmic Administration. Apply topically to the affected eye(s) as an ophthalmic solution.1 2 16 17 18 19 20 54 62 ... Apraclonidine Hydrochloride Dosage and Administration. Administration. For topical ophthalmic use only.62 Not for injection or ... mitomycin ophthalmic, Corgard, physostigmine ophthalmic, methazolamide, carbachol ophthalmic, Isopto Carpine, More... ... Postoperative Increased Intraocular Pressure Ilevro, Nevanac, nepafenac ophthalmic, Iopidine, apraclonidine ophthalmic, More... ...
  https://www.drugs.com/monograph/apraclonidine-hydrochloride.html
*  Cromolyn Sodium eent Monograph for Professionals - Drugs.com
Ophthalmic Administration. Applied topically to the eye as an ophthalmic solution just inside the lower eyelid; patients should ... Keratoconjunctivitis diclofenac ophthalmic, Maxitrol, cromolyn ophthalmic, Voltaren Ophthalmic, Blephamide, Cortisporin ... Conjunctivitis, Allergic prednisone, cetirizine ophthalmic, prednisolone ophthalmic, azelastine ophthalmic, Deltasone, cromolyn ... Ophthalmic. Ophthalmic Solution. 20-25°C or 15-30°C, depending on manufacturer; protect from light.205 206 208 209 213 216 b ...
  https://www.drugs.com/monograph/cromolyn-sodium-eent.html
*  Safety of Polyhexanide (PHMB) 0.08% ophthalmic solution after 26-week repeated-dose ocular administration in rabbits. | IOVS |...
Safety of Polyhexanide (PHMB) 0.08% ophthalmic solution after 26-week repeated-dose ocular administration in rabbits. ... Safety of Polyhexanide (PHMB) 0.08% ophthalmic solution after 26-week repeated-dose ocular administration in rabbits. ... ophthalmic solution after 26-week repeated-dose ocular administration in rabbits.. Invest. Ophthalmol. Vis. Sci. 2017;58(8): ... These favourable results strengthen our plan to develop PHMB 0.08% ophthalmic solution as a novel orphan drug for the treatment ...
  https://iovs.arvojournals.org/article.aspx?articleid=2642045
*  Patent US20110152767 - Method and Apparatus for Drug Delivery - Google Patentsuche
Methods of ophthalmic administration. US6520930 *. 3. Apr. 2001. 18. Febr. 2003. Medrad, Inc.. Injectors, injector systems and ... Ophthalmic Injection Method. US20080097379 *. 26. Sept. 2006. 24. Apr. 2008. Alcon Manufacturing, Ltd.. Ophthalmic injection ... Ophthalmic Injection Device Including Dosage Control Device. US20100057003 *. 9. Okt. 2007. 4. M rz 2010. Cesario Dos Santos. ... Method of Operating Ophthalmic Hand Piece with Disposable End. US20100106089 *. 1. Okt. 2007. 29. Apr. 2010. Cesario Dos Santos ...
  http://www.google.de/patents/US20110152767
*  Patent US4534348 - Instrument for making corneal incisions - Google Patents
Methods of ophthalmic administration. US6397849. Aug 2, 1999. Jun 4, 2002. Insite Vision Incorporated. Methods of ophthalmic ...
  http://www.google.com/patents/US4534348
*  Patent US5911707 - Needle guide - Google Patents
Methods of ophthalmic administration. US6397849. Aug 2, 1999. Jun 4, 2002. Insite Vision Incorporated. Methods of ophthalmic ... administration. US6428560. Feb 19, 2001. Aug 6, 2002. Christopher H. Green. Apparatus for safely removing a needle from a ...
  http://www.google.com/patents/US5911707?dq=7,328,163
*  Patent US8617094 - Fluid infusion methods for glaucoma treatment - Google Patent
Methods of ophthalmic administration. US6413540. 12 sep 2000. 2 jul 2002. Alcon Universal Ltd.. Drug delivery device. ... Ophthalmic device for draining excess intraocular fluid. US5629008. 7 jun 1994. 13 maj 1997. C.R. Bard, Inc.. Method and device ... Method of treating ophthalmic disorders using TGF -β. US5785674. 20 dec 1996. 28 jul 1998. Mateen; Ahmed Abdul. Device and ... Device and method for treating ophthalmic diseases. US6306120. 7 jun 1999. 23 okt 2001. Ben Gee Tan. Applicator and method for ...
  http://www.google.se/patents/US8617094
*  Drug Summary
Ophthalmic Administration. Instruct patient on proper instillation of eye solution.. Do not to touch the tip of the dropper to ... There have been reports that ophthalmic administration of diclofenac may cause increased bleeding of ocular tissues (including ... Ophthalmic Route. Systemic absorption from the ophthalmic formulation is not clinically significant. ... Administration of a CYP2C9 substrate, tolbutamide, on days 1, 4, 8, and 15 with a 3-day regimen of oral aprepitant (125 mg/80 ...
  http://www.pdr.net/drug-summary/Cambia-diclofenac-potassium-2426
*  Cysteamine Hydrochloride Monograph for Professionals - Drugs.com
Ophthalmic Administration. Apply topically to each eye as an ophthalmic solution; the solution is for topical ophthalmic use ... Pharmacokinetics not evaluated following ophthalmic administration.1 7. Distribution. Extent. Following oral administration, ... Effect of renal impairment on the pharmacokinetics of cysteamine following ophthalmic administration not evaluated because ... Peak concentrations of cysteamine following topical ophthalmic application of the ophthalmic solution not known.1 Because the ...
  https://www.drugs.com/monograph/cysteamine-hydrochloride.html
*  US7699882B2 - Apparatus and method for surgical bypass of aqueous humor - Google Patents
Methods of ophthalmic administration US6112747A (en) * 1998-11-06. 2000-09-05. Jones; Jesse M.. Method of sterilizing females ... Ophthalmic microsurgical system US8425449B2 (en) 2013-04-23. Ocular implants and methods for delivering ocular implants into ... Composite Ophthalmic Mikrokanuele US20070244520A1 (en) * 2004-04-19. 2007-10-18. Searete Llc. Lumen-traveling biological ... Methods and means for drug administration EP0723786A1 (en) * 1995-01-30. 1996-07-31. Cardiovascular Concepts, Inc.. Lesion ...
  https://patents.google.com/patent/US7699882B2/en
*  US20070134244A1 - Combination treatment for pathologic ocular angiogenesis - Google Patents
The combination therapy of the invention includes administration of anecortave acetate and bevacizumab or ranibizumab. ... Methods of ophthalmic administration ... The administration of anecortave acetate will be repeated at ... Subsequent administrations of anecortave acetate will occur no more than six months after the previous administrations. ... Subsequent administrations of bevacizumab will occur at six week intervals. If necessary, subsequent administrations of ...
  https://patents.google.com/patent/US20070134244A1/en
*  US7094226B2 - Ophthalmic drug delivery device - Google Patents
An ophthalmic drug delivery device having a first end and a second end, an injection port, a reservoir, and a sleeve is ... Methods of ophthalmic administration US6397849B1 (en) 1998-08-03. 2002-06-04. Insite Vision Incorporated. Methods of ophthalmic ... "A New method for Posterior Sub-Tenon's Drug Administration," Nesterov, et al., Ophthalmic Surgery, vol. 24, No. 1, Jan. 1993, ... US7094226B2 - Ophthalmic drug delivery device - Google Patents. Ophthalmic drug delivery device Download PDF Info. Publication ...
  https://patents.google.com/patent/US7094226B2/en
*  Drug Summary
Care should be taken to avoid use around the eyes; ophthalmic administration should be avoided. Visual impairment, ocular ... ADMINISTRATION. Topical Administration. Wash hands before and after application. Use gloves if required by universal ... Acne rosacea, acne vulgaris, cataracts, glaucoma, ocular exposure, ophthalmic administration, perioral dermatitis ... Administration of fluocinonide should be limited to the least amount compatible with an effective therapeutic regimen. If ...
  http://www.pdr.net/drug-summary/Vanos-fluocinonide-325
*  Besifloxacin Hydrochloride Monograph for Professionals - Drugs.com
Besifloxacin Hydrochloride Dosage and Administration. Administration. Ophthalmic Administration. Apply 0.6% ophthalmic ... erythromycin ophthalmic, gentamicin ophthalmic, bacitracin ophthalmic, tobramycin ophthalmic, moxifloxacin ophthalmic, TobraDex ... Conjunctivitis, Bacterial ciprofloxacin ophthalmic, azithromycin ophthalmic, levofloxacin ophthalmic, ... Administration Precautions. For topical ophthalmic use only;1 not for injection into the eye.1 ...
  https://www.drugs.com/monograph/besifloxacin-hydrochloride.html
*  Patent US5149320 - Composite anesthetic article and method of use - Google Patents
Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance. ... After the administration of the appropriate treatment the time for the onset of analgesia and the waiting time required before ... Intravenous administration of water soluble analgesic formulations. WO2008079818A3 *. Dec 18, 2007. Sep 12, 2008. Soluprin ... depends on the route and site of administration, the degree of vascularity at the site of infiltration, the pH of the ...
  http://www.google.com/patents/US5149320?dq=6,712,702
*  Zirgan New FDA Drug Approval | CenterWatch
... ganciclovir ophthalmic gel): For the treatment of acute herpetic keratitis. New approved drug details including side effects, ... Zirgan is supplied as a 0.15% gel designed for topical ophthalmic administration. The recommended initial dose is 1 drop in the ... Zirgan (ganciclovir ophthalmic gel). The following drug information is obtained from various newswires, published medical ... Colin J, Hoh HB, Easty DL, Herbort CP, Resnikoff S, Rigal D, Romdane K Ganciclovir ophthalmic gel (Virgan; 0.15%) in the ...
  http://www.centerwatch.com/drug-information/fda-approved-drugs/drug/1056/
*  US6033389A - Eye medicament dispensing device - Google Patents
Method for ophthalmic administration of medicament US20060224129A1 (en) * 1998-12-07. 2006-10-05. Beasley Jim C. Septum ... Method for ophthalmic administration of medicament US20070211212A1 (en) * 2002-09-26. 2007-09-13. Percy Bennwik. Eye state ... Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients US8939947B2 (en) 2005-03-04. 2015-01-27. C ... Method and Device for Ophthalmic Administration of Active Pharmaceutical Ingredients US20080319399A1 (en) * 2007-06-20. 2008-12 ...
  https://patents.google.com/patent/US6033389?oq=6%2C757%2C682
*  The Immune Protective Effect of the Mediterranean Diet against Chronic Low-grade Inflammatory Diseases | BenthamScience
Drug Delivery Systems for Ophthalmic Administration of Antiinflammatory Agents. Anti-Inflammatory & Anti-Allergy Agents in ...
  http://www.eurekaselect.com/124817/article